- Home
- IFRX vs MIND Comparison
IFRX vs MIND Comparison
Compare IFRX & MIND Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- IFRX
- MIND
- Stock Information
- Founded
- IFRX 2007
- MIND 1987
- Country
- IFRX Germany
- MIND United States
- Employees
- IFRX N/A
- MIND N/A
- Industry
- IFRX Biotechnology: Pharmaceutical Preparations
- MIND Industrial Machinery/Components
- Sector
- IFRX Health Care
- MIND Industrials
- Exchange
- IFRX Nasdaq
- MIND Nasdaq
- Market Cap
- IFRX 65.8M
- MIND 53.6M
- IPO Year
- IFRX 2017
- MIND 1994
- Fundamental
- Price
- IFRX $0.78
- MIND $6.18
- Analyst Decision
- IFRX Strong Buy
- MIND
- Analyst Count
- IFRX 4
- MIND 0
- Target Price
- IFRX $7.75
- MIND N/A
- AVG Volume (30 Days)
- IFRX 850.4K
- MIND 191.8K
- Earning Date
- IFRX 08-07-2025
- MIND 06-10-2025
- Dividend Yield
- IFRX N/A
- MIND N/A
- EPS Growth
- IFRX N/A
- MIND N/A
- EPS
- IFRX N/A
- MIND 2.91
- Revenue
- IFRX $140,242.00
- MIND $45,087,000.00
- Revenue This Year
- IFRX $3.36
- MIND $7.28
- Revenue Next Year
- IFRX $100.60
- MIND N/A
- P/E Ratio
- IFRX N/A
- MIND $2.13
- Revenue Growth
- IFRX 30.90
- MIND 26.68
- 52 Week Low
- IFRX $0.71
- MIND $3.05
- 52 Week High
- IFRX $2.82
- MIND $11.10
- Technical
- Relative Strength Index (RSI)
- IFRX 33.05
- MIND 45.69
- Support Level
- IFRX $0.81
- MIND $5.51
- Resistance Level
- IFRX $0.86
- MIND $7.20
- Average True Range (ATR)
- IFRX 0.06
- MIND 0.38
- MACD
- IFRX -0.03
- MIND -0.04
- Stochastic Oscillator
- IFRX 6.14
- MIND 39.64
About IFRX InflaRx N.V.
InflaRx NV is a clinical-stage biopharmaceutical company focused on applying proprietary anti-C5a/C5aR technology to discover and develop first-in-class, potent, and specific inhibitors of the complement activation factor known as C5a and its receptor known as C5aR. C5a is an inflammatory mediator involved in the progression of a wide variety of autoimmune and other inflammatory diseases. Its product candidate, vilobelimab, is a novel intravenously delivered first-in-class anti-C5a monoclonal antibody that selectively binds to free C5a and has demonstrated disease-modifying clinical activity and tolerability in multiple clinical settings.
About MIND MIND Technology Inc. (DE)
MIND Technology Inc provides technology and solutions for exploration, survey, and defense applications in oceanographic, hydrographic, defense, seismic, and security industries. The company operates in segments namely, Seamap Marine Products and Klein Marine Products helps manufacture and sell specialized, high-performance sonar and seismic equipment. The company generates more revenue from Seamap Marine Products. The company's geographical segments include the United States; China, Norway; Turkey; Singapore; and Canada & Other.